| Literature DB >> 31866749 |
Rutairat Suttisuwan1, Saranya Phunpruch2,3, Tanatorn Saisavoey4, Papassara Sangtanoo4,4,4, Nuttha Thongchul4,5, Aphichart Karnchanatat4,5.
Abstract
This study aims to determine the antioxidant activity of bioactive peptides derived from Synechococcus sp. VDW cells cultured for 21 days. Synechococcus sp. VDW protein hydrolysates were prepared with trypsin and purified by ultrafiltration with molecular mass cut-off membranes of 10, 5 and 3 kDa. The M<3 kDa (FA) fraction had the highest 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and 2,2'-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities, with IC50 values of (11.5±0.3) and (13.6±0.2) µg/mL, respectively. The FA fraction was separated by reversed phase HPLC to yield four subfractions (F1-4). The F4 subfraction showed the highest maximum ABTS radical scavenging activity (3.55±0.61) % and it was selected for further analysis by electrospray ionisation quadrupole time-of-flight mass spectrometry (ESI-Q-TOF-MS/MS) based on de novo peptide sequencing. Five antioxidant peptides were identified, of which AILESYSAGKTK had the highest ABTS radical scavenging activity. Furthermore, the FA fraction showed high cytotoxic activities against human cancer-derived cell lines, especially the colon cancer cell line (SW620) with an IC50 value of (106.6±21.5) µg/mL, but not the untransformed Wi38 cell line. The FA fraction activated the apoptotic pathway in SW620 cells after treatment for 24, 48 and 72 h, with the highest activities of caspases-3, -8 and -9 being observed after treatment for 72 h. These findings suggested that microalgae Synechococcus sp. VDW may be used to develop natural anticancer drugs.Entities:
Keywords: SW620 cell line; Synechococcus sp. VDW; antioxidant; apoptosis; cancer; protein hydrolysate
Year: 2019 PMID: 31866749 PMCID: PMC6902293 DOI: 10.17113/ftb.57.03.19.6028
Source DB: PubMed Journal: Food Technol Biotechnol ISSN: 1330-9862 Impact factor: 3.918
Fig. 1RP-HPLC chromatogram of the FA fraction of the crude Synechococcus sp. VDW protein hydrolysate showing the derived subfractions F1–4
Antioxidant activity of the five synthesized peptides at γ=1 mg/mL
| Peptide sequence | Formula | | Purity/% | DPPH scavenging activity/% | ABTS scavenging activity/% |
|---|---|---|---|---|---|
| AILESYSAGKTK | C56H95N15O18 | 1.27 | 99.2 | (16.6±0.1)b | (46.9±0.1)a |
| ALNKTHLIETK | C56H99N17O16 | 1.27 | 99.1 | (30.9±0.6)a | (4.2±0.4)c |
| IPDAHPVK | C40H65N11O11 | 0.88 | 94.8 | (7.7±0.7)c | (1.8±1.0)d |
| LLVHAPVK | C42H73N11O9 | 0.88 | 99.3 | (6.3±0.4)c | (3.78±1.1)c |
| VVVLRDGAVEELGTPR | C74H130N24O22 | 1.71 | 93.9 | (16.2±0.1)b | (11.6±1.9)b |
Data are presented as mean value±S.D. of triplicate independent repeats. Mean values with different letters in superscript within a column are significantly different (p≤0.05; Duncan’s multiple range test)
Cytotoxic effect of FA fraction on normal human cell lines and five cancer cell lines
| Cell line | IC50/(µg/mL) |
|---|---|
| Wi38 (normal human cells) | (538.3±3.8)e |
| BT474 (breast) | (155.1±6.2)ab |
| Chago-K1 (lung) | (164.7±10.7)b |
| Hep-G2 (hepatoma) | (166.8±19.6)c |
| KATO-III (gastric) | (270.1±26.5)d |
| SW620 (colon) | (106.6±21.5)a |
Data are presented as mean value+S.D. of three replicates. Different letters in superscript indicate significant differences among the groups according to Duncan’s test (p≤0.05)
Fig. 2Correlations of the growth inhibition of the SW620 cell line and: a) ABTS and b) DPPH free radical scavenging activities of FA fraction. Data plots are the mean values of three replications
Fig. 3Induction of apoptosis in SW620 cells by FA fraction (IC50=23.06 µg/mL) at: a) 24 h, b) 48 h and c) 72 h measured by flow cytometry (upper right quadrant indicates late apoptotic cells, upper left quadrant indicates necrotic cells, lower left quadrant indicates viable cells, and lower right quadrant indicates early apoptotic cells) compared to negative control (no FA) and positive control (γ(doxorubicin)=0.5 µg/mL). Plots are based on events (cells) and representative of those seen from three independent repeats
The proportion of early and total apoptotic SW620 cells as analysed by flow cytometry
| Apoptotic activity | |||
|---|---|---|---|
| 24 | 48 | 72 | |
| Early | |||
| Control | (10.51±2.50)ab | (7.57±0.69)d | (9.72±2.50)ab |
| Doxorubicin | (13.56±0.41)b | (19.13±2.24)c | (29.03±4.21)a |
| FA fraction | (32.11±1.16)d | (48.10±3.46)e | (52.24±1.09)e |
| Total | |||
| Control | (15.44±2.42)a | (16.77±3.14)ab | (24.72±7.58)b |
| Doxorubicin | (20.22±1.33)ab | (36.62±4.11)c | (63.18±2.64)a |
| FA fraction | (79.86±1.24)e | (95.85±2.46)f | (97.95±1.35)f |
Data are presented as mean value±S.D. of three replicates. Mean values with a different letter in superscript are significantly different (p≤0.05; Duncan's multiple range test)
Caspase-3, -8 and -9 activities in SW620 cells treated with FA fraction for 24–72 h
| | Activity/(µmol/(min·mL) | ||
|---|---|---|---|
| Caspase-3 | Caspase-8 | Caspase-9 | |
| Control | (10±7)c | (60±22)c | (1421±434)d |
| 24 | (30±19)c | (70±44)c | (1800±164)c |
| 48 | (100±7)b | (500±68)b | (10516±914)b |
| 72 | (160±7)a | (620±66)a | (16105±729)a |
Data are presented as mean value±S.D. of triplicate independent repeats. Mean values with a different letter in superscript within a column are significantly different (p≤0.05; Duncan’s multiple range test)